194 related articles for article (PubMed ID: 1331628)
21. Evaluation of steroid laboratory tests and adrenal gland imaging with radiocholesterol in the aetiological diagnosis of Cushing's syndrome.
Barbarino A; de Marinis L; Liberale I; Menini E
Clin Endocrinol (Oxf); 1979 Feb; 10(2):107-21. PubMed ID: 428112
[TBL] [Abstract][Full Text] [Related]
22. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome.
Avgerinos PC; Nieman LK; Oldfield EH; Cutler GB
Clin Endocrinol (Oxf); 1996 Oct; 45(4):483-91. PubMed ID: 8959090
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the integrated 3-hour plasma cortisol concentration as a test for Cushing's syndrome.
Desai RK; Jialal I; Naidoo C; Omar MA; Joubert SM
S Afr Med J; 1987 Feb; 71(3):156-7. PubMed ID: 3810361
[TBL] [Abstract][Full Text] [Related]
25. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
Batista DL; Riar J; Keil M; Stratakis CA
Pediatrics; 2007 Sep; 120(3):e575-86. PubMed ID: 17698579
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of Cushing's syndrome.
Hough FS
S Afr Med J; 1996 Aug; 86(8 Suppl):1022-5. PubMed ID: 9180774
[TBL] [Abstract][Full Text] [Related]
28. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
Streeten DH; Anderson GH; Brennan S; Jones C
J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
[TBL] [Abstract][Full Text] [Related]
29. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
Findling JW; Raff H; Aron DC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and imaging evaluation of Cushing's syndrome.
Newell-Price J; Grossman A
Minerva Endocrinol; 2002 Jun; 27(2):95-118. PubMed ID: 11961502
[TBL] [Abstract][Full Text] [Related]
31. Preclinical Cushing's syndrome in patients with an adrenal incidentaloma.
Tjan-Heijnen VC; Hermus AR; Kemink SA; Mudde AH; Pieters GF; Smals AG; Kloppenborg PW
Neth J Med; 1998 Mar; 52(3):111-5. PubMed ID: 9599968
[TBL] [Abstract][Full Text] [Related]
32. Plasma ACTH in diagnosis and control of adrenal disorders.
Girard J; Eberle AN; Baumann JB
Acta Endocrinol Suppl (Copenh); 1986; 279():254-8. PubMed ID: 3022521
[TBL] [Abstract][Full Text] [Related]
33. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.
Lacroix A; Bolté E; Tremblay J; Dupré J; Poitras P; Fournier H; Garon J; Garrel D; Bayard F; Taillefer R
N Engl J Med; 1992 Oct; 327(14):974-80. PubMed ID: 1325608
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
Görges R; Knappe G; Gerl H; Ventz M; Stahl F
J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
[TBL] [Abstract][Full Text] [Related]
35. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F
J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851
[TBL] [Abstract][Full Text] [Related]
36. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
37. [Value of the corticoliberine test in the etiologic diagnosis of Cushing's syndrome].
Tabarin A; San-Galli F; Guérin J; Corcuff B; Manciet G; Lefort G; Latapie JL; Roger P
Presse Med; 1990 Mar; 19(12):557-61. PubMed ID: 2158088
[TBL] [Abstract][Full Text] [Related]
38. Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.
Schteingart DE; Tsao HS
J Clin Endocrinol Metab; 1980 May; 50(5):961-6. PubMed ID: 6246139
[TBL] [Abstract][Full Text] [Related]
39. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.
Meikle AW
Clin Endocrinol (Oxf); 1982 Apr; 16(4):401-8. PubMed ID: 7094363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
